Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT-lymphoma)
disorderTreatments & Interventions
Clinical Trials
Recent Trials
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies
A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas
CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies
Research Evidence
Peer-reviewed studies linked via MeSH term "Lymphoma, B-Cell, Marginal Zone" from the MEDLINE/PubMed database.
Research data from MEDLINE/PubMed
Quick Facts
- SNOMED CT
- 445269007
- UMLS CUI
- C0242647
- Fully Specified Name
- Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- Known Treatments
- 2
- Clinical Trials
- 11
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.